Development of Mechanism to Solve the Shortage of Essential Controlled Medicines
Article Sidebar
Main Article Content
Abstract
The shortage of essential controlled medicines, such as lorazepam injection and
phenobarbital injection are impacting patient’s health. There has been management on
a case by case basis that might delay the patient’s accessibility to seizures control medicines
leading to fatality. Thus, it is necessary to develop a mechanism for handling the shortage
of essential controlled medicines. This study was using action research to analyze between
the current system and effective systems used abroad, and to develop effective mechanisms for solving the problem in Thailand. The study results found that 5 key components which make solving this problem successful are having a clear continuous government policy, proper laws, solution process, effective public relations and continuing knowledge development. For the effective mechanism to solve the shortage of essential controlled medicines of Thailand, consists of essential controlled medicines lists and solution process in ordinary case, emergency case and individual patients. The practical processes to be applied to the mechanism (1) Develop policies, laws and solution process by announcing it as the policy and mission of the Food and Drug Administration for cooperating with other government agencies and private organization (2) Legislation amendment to solve the problem of internationally controlled medicines shortage (3) Improve the pharmaceutical regulatory system to be more effective, such as expanding the express way for submitting the dossier of a lacking internationally controlled medicines for approval, special-access schemes for individual patients (4) Keep the lists of essential controlled medicines up-to-date and having clear criteria for physicians and patients for suggesting of inclusion of other essential controlled medicines (5) Provide and supply internationally controlled medicines in emergency situation
by The Narcotic Revolving Funds Office of the Food and Drug Administration and develop data systems such as the shortage drugs website and database of supply sources of internationally controlled medicines in producing countries.
Article Details
References
2.สำนักงานคณะกรรมการอาหารและยา สำนักยา.รายงานการพัฒนาระบบยาแห่งชาติประจำปี พ.ศ. 2557. 2557: 12-33.
3.U.S.Food and drug administration, Department of health and human service. Report on drug shortages for calendar year 2017. [internet]. 2018 [cited 2018 Nov15]. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM610662.pdf
4.FDA drug shortage. [Internet]. New Hampshire WebMD;20993 [updated 2018 Nov 21; cited
2018 Nov 25]. Available from: www.accessdata.fda.gov/scripts/drugshortages
5.U.S.Drug Enforcement Administration. DEA proposes reduction to amount of controlled
substances to be manufactured in 2018. [internet]. 2018 [cited 2018 Nov15]. Available
from: www.dea.gov/divisions/hq/2017/hq08417.shtml
6.The Society of Hospital Pharmacists of Australia. Medicine shortages in Australia: A snapshot of shortages in Australian hospitals.2017;1-17.
7.Therapeutic Goods Administration. Management and communication of medicine shortages and discontinuations in Australia. [internet]. 2018 [cited 2018 Nov30]. Available from: https://www.tga. gov.au/ sites/default/files/management-and-communicationmedicine shortages-and discontinuationsaustralia.
8.พระราชบัญญัติยาเสพติดให้โทษ พ.ศ. 2522 และ ฉบับแก้ไขเพิ่มเติม [อินเตอร์เน็ต]. [เข้าถึงเมื่อ 20
กุมภาพันธ์ 2562]. เข้าถึงได้จาก: http://web.krisdika.go.th/data/law/law2/%C207/%C207-20-9999-update.pdf
9.พระราชบัญญัติวัตถุที่ออกฤทธิ์ต่อจิตและประสาท พ.ศ. 2559. [อินเตอร์เน็ต]. 2559. [เข้าถึงเมื่อ 30
ตุลาคม 2561]. เข้าถึงได้จาก: http://web.krisdika.go.th/lawHeadContent.jsp?fromPage=law
HeadContent&formatFile=htm&hID=0